We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 162% below its sector, cheaper than its peers on earnings.
Guangxi Wuzhou Zhongheng Group Co., Ltd., operating from Wuzhou, China, specializes in the research, development, manufacturing, and distribution of pharmaceutical products across the nation. The company's diverse range of medicinal preparations includes pills, capsules, injections, and tablets, formulated to address various health concerns such as cardiovascular and cerebrovascular disorders, physical injuries, gynecological conditions, and respiratory ailments. In addition to its core pharmaceutical business, Guangxi Wuzhou Zhongheng Group also produces health food items, notably under its DOUBLE MONEY brand. Furthermore, its offerings encompass health-oriented functional beverages, various forms of turtle paste (including smokable and jelly types), and other related wellness products.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 600252.SS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
